A prospective real-world study of efgartigimod in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy
This study demonstrates the short-term efficacy and safety of efgartigimod in treating CIDP, suggesting its potential as a safe and effective alternative therapy. Further exploration is needed to determine its suitability for long-term maintenance treatment of CIDP.
Authors
- Yongbo Ma (ORCID: https://orcid.org/0009-0009-2676-3923)
- Han Zhou
- Geke Zhu (ORCID: https://orcid.org/0000-0002-6169-1912)
- L J Hao
- Gen Huang
- Wanying Wang
- Xiangtao Nie
- Wenjing Qi
- Xiuming Guo
Institutions
- People's Hospital of Bishan District (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Hanzhong Central Hospital (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.3389/fimmu.2026.1779544
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00